Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ASS1,Argininosuccinate synthase,Inverse variance weighted,2,1.26 [1.22-1.3],2.16255027540131e-47,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FUOM,Fucose mutarotase,Inverse variance weighted,2,1.2 [1.17-1.24],4.7359601596396e-38,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,2,1.2 [1.17-1.24],4.65937301517098e-37,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,2,1.19 [1.15-1.22],2.39053322780518e-34,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CBS,Cystathionine beta-synthase,Inverse variance weighted,2,1.19 [1.15-1.22],1.94104296855002e-30,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,2,1.16 [1.13-1.2],1.08804704033353e-25,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADH1B,All-trans-retinol dehydrogenase,Inverse variance weighted,2,1.17 [1.14-1.21],1.32207938201487e-25,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,2,1.15 [1.12-1.18],6.48591982402647e-22,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GSTA1,Glutathione S-transferase A1,Inverse variance weighted,2,1.19 [1.15-1.24],8.69026161235187e-22,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Inverse variance weighted,2,1.18 [1.14-1.22],2.90699128563031e-21,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,2,1.14 [1.11-1.17],9.51470287323362e-21,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,2,1.13 [1.1-1.16],1.40022669974392e-20,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,2,1.13 [1.1-1.16],1.00616079760105e-19,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACY1,Aminoacylase-1,Inverse variance weighted,2,1.13 [1.1-1.16],2.25357024850468e-19,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C19orf12,Protein C19orf12,Inverse variance weighted,2,1.17 [1.13-1.21],3.13718145057902e-19,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,2,1.13 [1.1-1.16],3.31249122479209e-19,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,2,1.13 [1.1-1.16],3.58201550886144e-19,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C7,Complement component C7,Inverse variance weighted,2,1.12 [1.09-1.15],9.1633691542997e-18,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALDH1A1,Retinal dehydrogenase 1,Inverse variance weighted,2,1.13 [1.1-1.16],1.17083771815136e-17,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCLY,Selenocysteine lyase,Inverse variance weighted,2,1.13 [1.1-1.16],1.26613975730233e-17,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,2,1.13 [1.1-1.16],1.96933885110516e-17,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALCAM,CD166 antigen,Inverse variance weighted,2,1.14 [1.1-1.17],7.61461805764927e-17,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,2,1.11 [1.08-1.14],1.27315341877827e-16,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THBS2,Thrombospondin-2,Inverse variance weighted,2,1.12 [1.09-1.15],2.16473926472504e-16,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,2,1.11 [1.08-1.14],3.18169939765421e-16,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,2,1.12 [1.09-1.15],3.90341988875214e-16,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,2,1.14 [1.1-1.17],7.73405778513825e-16,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SORD,Sorbitol dehydrogenase,Inverse variance weighted,2,1.12 [1.09-1.15],1.00764271147421e-15,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NFASC,Neurofascin,Inverse variance weighted,2,1.11 [1.08-1.14],1.30154816009076e-15,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LTA,Lymphotoxin-alpha,Inverse variance weighted,2,1.1 [1.08-1.13],1.74716196405932e-15,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,2,1.11 [1.08-1.14],1.57112508163918e-14,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,2,1.11 [1.08-1.14],3.20151987823761e-14,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,2,1.11 [1.08-1.14],5.79788611854892e-14,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.11 [1.08-1.15],6.43657979849571e-14,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,2,1.11 [1.08-1.14],7.23232561494068e-14,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Inverse variance weighted,2,1.13 [1.09-1.17],8.14959930454842e-14,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,2,1.11 [1.08-1.14],1.70735849367396e-13,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,2,1.1 [1.07-1.13],1.81921207605895e-13,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,2,1.11 [1.08-1.14],2.21209579645837e-13,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENTR1,Endosome-associated-trafficking regulator 1,Inverse variance weighted,2,1.12 [1.09-1.15],2.39675758586511e-13,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPP1,Osteopontin,Inverse variance weighted,2,1.11 [1.08-1.14],2.62987790599422e-13,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,2,1.11 [1.08-1.14],8.6683852688204e-13,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.11 [1.08-1.14],2.24480907665219e-12,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KYNU,Kynureninase,Inverse variance weighted,2,1.18 [1.13-1.24],2.92163487675495e-12,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,2,1.1 [1.07-1.13],3.05069497951877e-12,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLSTN2,Calsyntenin-2,Inverse variance weighted,2,1.1 [1.07-1.13],3.81377254442114e-12,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NRP1,Neuropilin-1,Inverse variance weighted,2,1.1 [1.07-1.13],6.37302663351404e-12,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,2,0.91 [0.89-0.93],8.16577949582802e-12,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDC1,Syndecan-1,Inverse variance weighted,2,1.1 [1.07-1.13],8.80728524115052e-12,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ROBO1,Roundabout homolog 1,Inverse variance weighted,2,1.1 [1.07-1.13],1.53087486486627e-11,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,2,1.1 [1.07-1.13],1.74186510653509e-11,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,2,1.12 [1.09-1.16],1.99614658711807e-11,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TLR3,Toll-like receptor 3,Inverse variance weighted,2,1.09 [1.07-1.12],2.9979061761815e-11,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,2,1.09 [1.06-1.12],3.49807664437533e-11,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,2,1.08 [1.06-1.11],3.91623199407885e-11,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RBKS,Ribokinase,Inverse variance weighted,2,1.1 [1.07-1.13],6.02164280698446e-11,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MARCO,Macrophage receptor MARCO,Inverse variance weighted,2,1.1 [1.07-1.13],6.63434560035793e-11,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADA2,Adenosine deaminase 2,Inverse variance weighted,2,1.13 [1.09-1.18],6.86068347552437e-11,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,2,1.09 [1.06-1.12],1.39402613016872e-10,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,2,1.09 [1.06-1.12],2.99263046853508e-10,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TCOF1,Treacle protein,Inverse variance weighted,2,1.1 [1.07-1.13],3.32401856079141e-10,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,2,1.09 [1.06-1.12],3.62196706071757e-10,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,2,1.11 [1.07-1.15],3.73489765240201e-10,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,2,1.09 [1.06-1.12],3.88378221302993e-10,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH6,Cadherin-6,Inverse variance weighted,2,1.08 [1.06-1.11],4.93957101537251e-10,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,2,1.09 [1.06-1.12],5.70863013259127e-10,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC9,Sialic acid-binding Ig-like lectin 9,Inverse variance weighted,2,1.07 [1.05-1.1],8.42190441803544e-10,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DCXR,L-xylulose reductase,Inverse variance weighted,2,1.14 [1.09-1.18],1.12992117700823e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Inverse variance weighted,2,1.07 [1.05-1.1],1.18199654337819e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPON2,Spondin-2,Inverse variance weighted,2,1.09 [1.06-1.12],1.7643771664208e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,2,1.08 [1.05-1.11],3.27006180641689e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,2,1.09 [1.06-1.12],3.7803966397351e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BOC,Brother of CDO,Inverse variance weighted,2,1.09 [1.06-1.12],3.81923888902284e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,2,1.09 [1.06-1.12],3.99407992233219e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HNMT,Histamine N-methyltransferase,Inverse variance weighted,2,1.11 [1.07-1.15],4.29707749039751e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,2,1.09 [1.06-1.12],4.70607194333521e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,2,1.08 [1.05-1.11],4.73645504045067e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,UPB1,Beta-ureidopropionase,Inverse variance weighted,2,1.15 [1.1-1.21],5.8356890168852e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,2,1.08 [1.05-1.11],6.15205970341776e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGB7,Integrin beta-7,Inverse variance weighted,2,1.08 [1.05-1.11],6.51965204791155e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,2,1.09 [1.06-1.12],6.70913546684714e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HMOX1,Heme oxygenase 1,Inverse variance weighted,2,1.11 [1.07-1.14],8.39791878161723e-09,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,2,1.08 [1.05-1.12],1.58109656678571e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,2,1.07 [1.05-1.1],1.94843032250535e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,2,1.09 [1.06-1.13],2.17430916659449e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SELE,E-selectin,Inverse variance weighted,2,1.07 [1.05-1.1],2.21447639385943e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEMA7A,Semaphorin-7A,Inverse variance weighted,2,1.08 [1.05-1.11],2.39981050001748e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,2,1.08 [1.05-1.11],2.58778368330922e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,2,1.09 [1.05-1.12],3.48687551435099e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NRP2,Neuropilin-2,Inverse variance weighted,2,1.08 [1.05-1.11],3.75550145123989e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,APOL1,Apolipoprotein L1,Inverse variance weighted,2,0.93 [0.9-0.95],3.75676740797467e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRM,Receptor-type tyrosine-protein phosphatase mu,Inverse variance weighted,2,1.08 [1.05-1.11],3.86693344230036e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL3,C-C motif chemokine 3,Inverse variance weighted,2,1.08 [1.05-1.11],4.1857481767711e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,2,1.08 [1.05-1.11],5.33443769821151e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,2,1.08 [1.05-1.11],5.82786936744595e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,2,1.08 [1.05-1.11],6.02309827728278e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENG,Endoglin,Inverse variance weighted,2,1.08 [1.05-1.11],6.73906100679371e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,1.08 [1.05-1.11],7.39466055852416e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLUL1,Clusterin-like protein 1,Inverse variance weighted,2,1.06 [1.04-1.09],7.91586005837219e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DKK3,Dickkopf-related protein 3,Inverse variance weighted,2,1.07 [1.05-1.1],8.01190620581596e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF8,SLAM family member 8,Inverse variance weighted,2,1.08 [1.05-1.11],9.25058185975435e-08,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SHBG,Sex hormone-binding globulin,Inverse variance weighted,2,1.07 [1.05-1.1],1.0101585404061e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,2,1.08 [1.05-1.11],1.07079699735071e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAMB1,Laminin subunit beta-1,Inverse variance weighted,2,1.07 [1.04-1.09],1.09142779716116e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,2,1.08 [1.05-1.11],1.1091792799811e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,2,1.08 [1.05-1.1],1.20232772731602e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BCAM,Basal cell adhesion molecule,Inverse variance weighted,2,1.07 [1.05-1.1],1.48392533482086e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRTG,Protogenin,Inverse variance weighted,2,1.07 [1.05-1.1],1.61579352472158e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHRDL2,Chordin-like protein 2,Inverse variance weighted,2,1.08 [1.05-1.11],1.64000558051725e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,2,1.08 [1.05-1.11],1.81040335604501e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,2,1.08 [1.05-1.11],1.83702017897769e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD83,CD83 antigen,Inverse variance weighted,2,1.08 [1.05-1.11],2.00780903119039e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GDF15,Growth/differentiation factor 15,Inverse variance weighted,2,1.06 [1.04-1.09],2.06526348129789e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,2,1.07 [1.04-1.1],2.22263976883672e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,2,1.07 [1.04-1.09],2.29579401070025e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,2,1.07 [1.05-1.1],2.4612386064145e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,2,1.08 [1.05-1.11],2.64158363800179e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,2,1.08 [1.05-1.11],3.04620020610168e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,2,1.07 [1.04-1.1],3.7368815904308e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FBLN2,Fibulin-2,Inverse variance weighted,2,1.07 [1.04-1.1],4.22631240874002e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CNTN4,Contactin-4,Inverse variance weighted,2,1.07 [1.04-1.1],5.07036437232959e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Inverse variance weighted,2,1.07 [1.04-1.1],6.42378013464827e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GGH,Gamma-glutamyl hydrolase,Inverse variance weighted,2,1.07 [1.04-1.1],7.21794991527407e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDC4,Syndecan-4,Inverse variance weighted,2,0.93 [0.91-0.96],7.2231725396095e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LY75,Lymphocyte antigen 75,Inverse variance weighted,2,1.06 [1.04-1.08],7.91949730685968e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDH17,Protocadherin-17,Inverse variance weighted,2,1.07 [1.04-1.1],9.12427670791796e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NELL2,Protein kinase C-binding protein NELL2,Inverse variance weighted,2,1.07 [1.04-1.1],9.78483669849471e-07,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,2,1.09 [1.06-1.13],1.0632336753769e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,2,1.12 [1.07-1.18],1.0676578319299e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DDR1,Epithelial discoidin domain-containing receptor 1,Inverse variance weighted,2,1.09 [1.05-1.12],1.1301255467991e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,2,1.09 [1.05-1.13],1.8173502928592e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,2,1.07 [1.04-1.1],1.83417410785089e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.07 [1.04-1.1],1.90519718033118e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",Inverse variance weighted,2,1.06 [1.04-1.09],1.97171103780284e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,2,1.07 [1.04-1.1],2.89379905674105e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,2,1.07 [1.04-1.1],3.13012021048165e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CALCA,Calcitonin,Inverse variance weighted,2,1.06 [1.03-1.08],3.41388526165063e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,2,1.07 [1.04-1.1],3.64939882051706e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ISM1,Isthmin-1,Inverse variance weighted,2,1.07 [1.04-1.1],4.07353614798645e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,2,1.06 [1.04-1.09],4.15404014574077e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,2,1.07 [1.04-1.1],4.20837048316521e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KEL,Kell blood group glycoprotein,Inverse variance weighted,2,1.06 [1.03-1.09],4.20904138766636e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FSTL3,Follistatin-related protein 3,Inverse variance weighted,2,1.07 [1.04-1.1],4.2348757696988e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TYRO3,Tyrosine-protein kinase receptor TYRO3,Inverse variance weighted,2,1.06 [1.03-1.09],4.95472393162158e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRUNE2,Protein prune homolog 2,Inverse variance weighted,2,1.07 [1.04-1.1],6.12028948705778e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,2,1.06 [1.04-1.09],6.58974207365124e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,2,1.17 [1.09-1.25],6.61385458189149e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,2,1.06 [1.03-1.09],7.75299722866598e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,2,1.06 [1.03-1.09],9.79266972023309e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,2,1.12 [1.07-1.18],9.86122180876491e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD22,B-cell receptor CD22,Inverse variance weighted,2,1.06 [1.03-1.09],1.04918204959197e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,2,1.06 [1.03-1.09],1.10456346271373e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,2,1.06 [1.04-1.09],1.20618768002097e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DSCAM,Down syndrome cell adhesion molecule,Inverse variance weighted,2,1.07 [1.04-1.11],1.39190994729167e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL32,Interleukin-32,Inverse variance weighted,2,1.1 [1.05-1.15],1.70033846243671e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD109,CD109 antigen,Inverse variance weighted,2,1.05 [1.03-1.07],1.8025338970831e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,2,1.06 [1.03-1.09],1.88743283925845e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CFHR5,Complement factor H-related protein 5,Inverse variance weighted,2,0.94 [0.92-0.97],1.94493857005815e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,2,1.06 [1.03-1.09],1.94850726999517e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,2,1.06 [1.03-1.09],1.98428673573727e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,2,0.95 [0.93-0.97],2.02223907382026e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,2,1.09 [1.05-1.13],2.1696963175637e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,2,1.04 [1.02-1.06],2.27193128656995e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MILR1,Allergin-1,Inverse variance weighted,2,1.06 [1.03-1.09],2.31160540590189e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,2,1.07 [1.04-1.11],3.16583684757475e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THOP1,Thimet oligopeptidase,Inverse variance weighted,2,1.06 [1.03-1.09],3.29158573162496e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,2,1.06 [1.03-1.08],3.3253911237327e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FSTL1,Follistatin-related protein 1,Inverse variance weighted,2,1.06 [1.03-1.09],3.74944660051576e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD48,CD48 antigen,Inverse variance weighted,2,1.07 [1.04-1.1],3.77098439813448e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD276,CD276 antigen,Inverse variance weighted,2,1.05 [1.03-1.08],3.90702642042909e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSL,Cathepsin L1,Inverse variance weighted,2,1.06 [1.03-1.09],4.22568311354838e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDHB15,Protocadherin beta-15,Inverse variance weighted,2,1.06 [1.03-1.09],4.24839369901196e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KHK,Ketohexokinase,Inverse variance weighted,2,1.11 [1.06-1.17],4.54219656306618e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDCD1,Programmed cell death protein 1,Inverse variance weighted,2,1.06 [1.03-1.09],5.1362431074962e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,2,1.06 [1.03-1.09],5.33131048101202e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,2,1.07 [1.04-1.11],5.53048117457512e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,2,1.08 [1.04-1.12],5.8988954003086e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AREG,Amphiregulin,Inverse variance weighted,2,1.06 [1.03-1.09],7.82346893066482e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDGFRB,Platelet-derived growth factor receptor beta,Inverse variance weighted,2,1.05 [1.03-1.08],8.16017381686194e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THBS4,Thrombospondin-4,Inverse variance weighted,2,1.06 [1.03-1.09],8.40971317838412e-05,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,2,1.05 [1.03-1.08],0.000108778825698449,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,2,1.06 [1.03-1.09],0.000113610596559106,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,2,0.9 [0.86-0.95],0.000129383272768404,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,2,1.06 [1.03-1.09],0.00013532038038667,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CR1,Complement receptor type 1,Inverse variance weighted,2,1.05 [1.02-1.08],0.000141593493309308,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH5,Cadherin-5,Inverse variance weighted,2,1.05 [1.02-1.08],0.000148404465521806,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCN2,Ficolin-2,Inverse variance weighted,2,0.95 [0.93-0.98],0.000151278702173049,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,2,1.09 [1.04-1.14],0.000153529880509928,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEZ6L,Seizure 6-like protein,Inverse variance weighted,2,1.05 [1.03-1.08],0.000159751022964755,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,2,1.06 [1.03-1.09],0.000161095957479907,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCRLB,Fc receptor-like B,Inverse variance weighted,2,1.05 [1.02-1.07],0.000169244374690042,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.05 [1.03-1.08],0.000169852937481564,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,2,1.05 [1.02-1.08],0.000185347165364061,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TIE1,Tyrosine-protein kinase receptor Tie-1,Inverse variance weighted,2,1.05 [1.02-1.08],0.000187757642500287,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,2,1.05 [1.02-1.07],0.000196975054803906,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GOT1,"Aspartate aminotransferase, cytoplasmic",Inverse variance weighted,2,1.14 [1.06-1.22],0.000203862326842247,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGB2,Integrin beta-2,Inverse variance weighted,2,1.05 [1.03-1.08],0.000208255922766506,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AKR1B10,Aldo-keto reductase family 1 member B10,Inverse variance weighted,2,1.06 [1.03-1.09],0.00020976064143175,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,2,1.05 [1.02-1.08],0.000238300302445272,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,2,1.09 [1.04-1.14],0.000259922680107557,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,2,1.05 [1.02-1.08],0.000264607680427518,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHRDL1,Chordin-like protein 1,Inverse variance weighted,2,1.05 [1.02-1.08],0.000276048084361093,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,2,1.05 [1.02-1.08],0.000293073346322399,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,2,1.07 [1.03-1.1],0.000320183230346959,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,2,1.05 [1.02-1.08],0.00033912542894023,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD300C,CMRF35-like molecule 6,Inverse variance weighted,2,1.05 [1.02-1.08],0.000360502245421553,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNXB,Tenascin-X,Inverse variance weighted,2,1.05 [1.02-1.08],0.000363304899219909,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDH12,Protocadherin-12,Inverse variance weighted,2,1.05 [1.02-1.08],0.000368029416029388,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACHE,Acetylcholinesterase,Inverse variance weighted,2,1.09 [1.04-1.14],0.000404373042818885,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSD,Cathepsin D,Inverse variance weighted,2,1.08 [1.03-1.12],0.000437175514261004,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SGSH,N-sulphoglucosamine sulphohydrolase,Inverse variance weighted,2,1.1 [1.04-1.16],0.000443011614271808,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,2,1.05 [1.02-1.08],0.000450945074711771,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGA5,Integrin alpha-5,Inverse variance weighted,2,1.07 [1.03-1.11],0.000464740789548283,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,2,1.05 [1.02-1.08],0.000466930797973093,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,2,1.05 [1.02-1.08],0.000544360457948411,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,2,1.04 [1.02-1.06],0.000549418525920718,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,2,1.05 [1.02-1.07],0.000578418560765743,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.05 [1.02-1.08],0.000601163018486836,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,2,0.95 [0.93-0.98],0.000602533815883045,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.05 [1.02-1.08],0.000605483805858456,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PKD1,Polycystin-1,Inverse variance weighted,2,1.05 [1.02-1.08],0.000764961435057647,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.1 [1.04-1.16],0.000800393539929883,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPVL,Probable serine carboxypeptidase CPVL,Inverse variance weighted,2,1.04 [1.02-1.07],0.000823004045860894,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FRZB,Secreted frizzled-related protein 3,Inverse variance weighted,2,1.05 [1.02-1.09],0.000871391289360691,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",Inverse variance weighted,2,1.05 [1.02-1.09],0.000904105459681668,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.05 [1.02-1.08],0.000922207269202056,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,2,1.05 [1.02-1.08],0.000952660748267798,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AOC3,Membrane primary amine oxidase,Inverse variance weighted,2,1.08 [1.03-1.13],0.000987529087549283,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.05 [1.02-1.08],0.00102673046580634,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GZMA,Granzyme A,Inverse variance weighted,2,1.05 [1.02-1.08],0.00102983616204371,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDK2,Protein sidekick-2,Inverse variance weighted,2,1.05 [1.02-1.07],0.00116232482132677,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VSIG10,V-set and immunoglobulin domain-containing protein 10,Inverse variance weighted,2,1.04 [1.02-1.07],0.00117279179819109,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.05 [1.02-1.08],0.00119916266804713,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VCAN,Versican core protein,Inverse variance weighted,2,1.04 [1.02-1.07],0.00122227508122328,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,1.08 [1.03-1.13],0.00127381286223879,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,2,1.04 [1.02-1.07],0.00129498195865794,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,2,1.04 [1.02-1.07],0.00140715447669723,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GPD1,Glycerol-3-phosphate dehydrogenase,Inverse variance weighted,2,1.09 [1.04-1.16],0.00145220999677373,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,2,1.05 [1.02-1.07],0.00146836621673407,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,2,1.05 [1.02-1.08],0.00153580545192273,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,2,1.05 [1.02-1.08],0.00162226830441008,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSS,Cathepsin S,Inverse variance weighted,2,1.06 [1.02-1.1],0.00182755450268277,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,2,1.06 [1.02-1.09],0.00198800219404605,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,2,1.04 [1.01-1.06],0.00218112896440038,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,2,1.04 [1.02-1.07],0.00248943828461136,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,2,1.04 [1.02-1.07],0.00252958289251066,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,2,1.06 [1.02-1.1],0.00287150370270128,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEZ6,Seizure protein 6 homolog,Inverse variance weighted,2,1.05 [1.02-1.08],0.00289966161978776,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,Inverse variance weighted,2,1.05 [1.02-1.08],0.00295668501949689,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,2,1.07 [1.02-1.12],0.00299990491423045,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,2,1.04 [1.01-1.07],0.00307752939321328,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.96 [0.93-0.99],0.00308684183423142,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.04 [1.01-1.07],0.00309240311655819,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,2,1.04 [1.01-1.07],0.00313021939725225,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,Inverse variance weighted,2,1.04 [1.01-1.07],0.00330281552342728,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.04 [1.01-1.07],0.00365201298120304,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGALS9,Galectin-9,Inverse variance weighted,2,1.04 [1.01-1.07],0.00368355719377108,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,2,1.03 [1.01-1.06],0.00373561537320082,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD86,T-lymphocyte activation antigen CD86,Inverse variance weighted,2,1.08 [1.02-1.13],0.00376280245507487,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,OCLN,Occludin,Inverse variance weighted,2,1.05 [1.02-1.09],0.00429069781105712,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,2,1.05 [1.02-1.09],0.00443421820423024,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDHR2,Cadherin-related family member 2,Inverse variance weighted,2,1.04 [1.01-1.06],0.00453982373295068,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,2,1.06 [1.02-1.1],0.00463040833190416,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PALM2,Paralemmin-2,Inverse variance weighted,2,1.08 [1.02-1.14],0.00464182022851053,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,2,1.04 [1.01-1.08],0.00472590835719877,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLIT2,Slit homolog 2 protein,Inverse variance weighted,2,1.04 [1.01-1.08],0.00499056901384421,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,2,1.05 [1.02-1.09],0.00510575489463483,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,2,0.97 [0.94-0.99],0.00518124557914419,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KCTD5,BTB/POZ domain-containing protein KCTD5,Inverse variance weighted,2,1.06 [1.02-1.11],0.00521753299113781,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,2,1.04 [1.01-1.07],0.00543539413596388,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLXNB2,Plexin-B2,Inverse variance weighted,2,1.04 [1.01-1.08],0.00570013165718675,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDH9,Protocadherin-9,Inverse variance weighted,2,1.08 [1.02-1.14],0.00604726263016145,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SERPINA9,Serpin A9,Inverse variance weighted,2,1.04 [1.01-1.06],0.00622127772410673,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,2,1.05 [1.01-1.09],0.00642062699253123,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,Inverse variance weighted,2,1.04 [1.01-1.07],0.00686236141697292,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,2,1.04 [1.01-1.06],0.00712016615371989,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VSNL1,Visinin-like protein 1,Inverse variance weighted,2,1.08 [1.02-1.15],0.00743500205255034,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLSTN3,Calsyntenin-3,Inverse variance weighted,2,1.04 [1.01-1.07],0.00771983709106015,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,UXS1,UDP-glucuronic acid decarboxylase 1,Inverse variance weighted,2,1.04 [1.01-1.07],0.00791258235334296,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCRL1,Fc receptor-like protein 1,Inverse variance weighted,2,1.06 [1.02-1.11],0.00817862906565792,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,2,1.03 [1.01-1.06],0.00845521820283777,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,2,1.04 [1.01-1.07],0.0088187770617093,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,2,1.04 [1.01-1.07],0.00930803768196459,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAYN,Layilin,Inverse variance weighted,2,1.04 [1.01-1.06],0.0095999128499868,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PGF,Placenta growth factor,Inverse variance weighted,2,1.03 [1.01-1.06],0.00986335840371407,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TSPAN8,Tetraspanin-8,Inverse variance weighted,2,1.03 [1.01-1.06],0.0101009321876439,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,2,1.04 [1.01-1.06],0.0110770205192262,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,Inverse variance weighted,2,1.07 [1.01-1.12],0.0122485242382497,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLEC11A,C-type lectin domain family 11 member A,Inverse variance weighted,2,1.04 [1.01-1.07],0.0128967096120407,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TLR1,Toll-like receptor 1,Inverse variance weighted,2,1.04 [1.01-1.07],0.0133687835558456,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TEK,Angiopoietin-1 receptor,Inverse variance weighted,2,1.03 [1.01-1.06],0.0135152634915544,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CA9,Carbonic anhydrase 9,Inverse variance weighted,2,1.05 [1.01-1.08],0.0138859429002577,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,Inverse variance weighted,2,1.04 [1.01-1.07],0.0140504095584604,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,2,1.04 [1.01-1.07],0.0149977134586606,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,2,1.08 [1.01-1.14],0.0150046245842073,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,Inverse variance weighted,2,1.03 [1.01-1.05],0.0150345451408473,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,2,1.04 [1.01-1.07],0.0150383482646735,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD248,Endosialin,Inverse variance weighted,2,1.05 [1.01-1.1],0.0151213670809415,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,2,1.03 [1.01-1.06],0.0172619144444717,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,2,1.03 [1.01-1.06],0.0181424316853104,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CR2,Complement receptor type 2,Inverse variance weighted,2,1.03 [1.01-1.06],0.018576174437165,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,2,1.03 [1.01-1.06],0.0185982135437636,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,2,1.14 [1.02-1.27],0.0192240285502335,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.06 [1.01-1.11],0.0192477555387757,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSC,Dipeptidyl peptidase 1,Inverse variance weighted,2,1.05 [1.01-1.09],0.0201559794323858,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.03 [1.01-1.06],0.0202493825885191,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC1,Sialoadhesin,Inverse variance weighted,2,1.03 [1-1.06],0.0207604979665349,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,2,1.05 [1.01-1.09],0.0208816143417082,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,1.09 [1.01-1.17],0.0219450146971902,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,2,1.03 [1-1.06],0.0219980797821168,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.08 [1.01-1.15],0.0220370533810171,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,INSR,Insulin receptor,Inverse variance weighted,2,1.03 [1-1.07],0.0228040537280489,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AMOT,Angiomotin,Inverse variance weighted,2,1.05 [1.01-1.09],0.0230032387561995,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,2,1.03 [1-1.06],0.0232753149875635,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,2,1.03 [1-1.06],0.0233925490808385,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,2,1.04 [1.01-1.07],0.0235207314002821,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH2,Cadherin-2,Inverse variance weighted,2,1.08 [1.01-1.15],0.0301660637644207,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BSG,Basigin,Inverse variance weighted,2,1.04 [1-1.08],0.0303262181260943,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,2,1.03 [1-1.06],0.0303917789235485,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,2,1.04 [1-1.07],0.0310287026653957,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,2,1.04 [1-1.08],0.0321884616376201,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,2,1.03 [1-1.06],0.0322417404775564,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,2,1.02 [1-1.05],0.0322540007820559,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,2,1.03 [1-1.06],0.0328342370149223,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Inverse variance weighted,2,1.03 [1-1.06],0.0330642300571011,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,2,1.03 [1-1.06],0.0345480355397695,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ARSA,Arylsulfatase A,Inverse variance weighted,2,1.09 [1.01-1.17],0.0351444359204191,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ULBP2,UL16-binding protein 2,Inverse variance weighted,2,1.03 [1-1.06],0.036776572927431,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IDUA,Alpha-L-iduronidase,Inverse variance weighted,2,1.09 [1-1.18],0.0373017928474658,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,1.03 [1-1.06],0.037594640761148,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,2,1.05 [1-1.1],0.0378287375668562,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD300E,CMRF35-like molecule 2,Inverse variance weighted,2,1.03 [1-1.06],0.0388160106604189,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCRL5,Fc receptor-like protein 5,Inverse variance weighted,2,1.03 [1-1.06],0.0389103066916602,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.03 [1-1.06],0.0403885529781954,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPT2,Angiopoietin-2,Inverse variance weighted,2,1.03 [1-1.06],0.0412627907473007,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,2,1.07 [1-1.15],0.0415676647658125,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,2,1.03 [1-1.06],0.0416180433626771,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,2,1.02 [1-1.05],0.0430234830166996,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,2,1.03 [1-1.06],0.0430746756152496,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,2,1.03 [1-1.06],0.0431340455886759,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PVR,Poliovirus receptor,Inverse variance weighted,2,1.02 [1-1.05],0.0441858173004344,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGB1,Integrin beta-1,Inverse variance weighted,2,1.05 [1-1.1],0.0444170161039573,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ECE1,Endothelin-converting enzyme 1,Inverse variance weighted,2,1.03 [1-1.06],0.0455582924052514,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SERPINA7,Thyroxine-binding globulin,Inverse variance weighted,2,1.04 [1-1.08],0.0463784419249787,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GSR,"Glutathione reductase, mitochondrial",Inverse variance weighted,2,1.06 [1-1.12],0.0468015089165936,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,2,1.06 [1-1.12],0.0472017382317054,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,2,1.03 [1-1.05],0.0498749575737011,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,2,1.03 [1-1.07],0.0498833407174557,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,2,1.04 [1-1.09],0.0519685188333225,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,2,1.03 [1-1.05],0.054975189807381,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,2,1.05 [1-1.1],0.0573665387058244,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,2,1.03 [1-1.06],0.0589599851996157,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD55,Complement decay-accelerating factor,Inverse variance weighted,2,1.03 [1-1.06],0.0613452197518953,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HEG1,Protein HEG homolog 1,Inverse variance weighted,2,1.04 [1-1.08],0.0636210721431836,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,2,1.03 [1-1.05],0.0647499344505256,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALDH2,"Aldehyde dehydrogenase, mitochondrial",Inverse variance weighted,2,1.04 [1-1.09],0.0684196487725232,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LY96,Lymphocyte antigen 96,Inverse variance weighted,2,1.03 [1-1.06],0.0701907897755118,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,2,1.02 [1-1.05],0.0775575196116803,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRSS8,Prostasin,Inverse variance weighted,2,0.97 [0.93-1],0.0784549478431035,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GUSB,Beta-glucuronidase,Inverse variance weighted,2,1.11 [0.99-1.24],0.0796193310063336,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.05 [0.99-1.11],0.082208193997759,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Inverse variance weighted,2,1.05 [0.99-1.12],0.0826079462351582,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,2,1.02 [1-1.05],0.0834765549826938,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,2,1.03 [1-1.05],0.0854702275390304,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GOLM2,Protein GOLM2,Inverse variance weighted,2,1.03 [1-1.05],0.0855588051108768,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,2,1.07 [0.99-1.15],0.0872321092996275,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CREG1,Protein CREG1,Inverse variance weighted,2,1.14 [0.98-1.32],0.0872368215498472,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VWF,von Willebrand factor,Inverse variance weighted,2,1.02 [1-1.05],0.0895645372378494,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,2,1.02 [1-1.05],0.0931631792616496,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.04 [0.99-1.08],0.0938081908718747,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD5L,CD5 antigen-like,Inverse variance weighted,2,1.02 [1-1.05],0.0954933686511881,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL18,Interleukin-18,Inverse variance weighted,2,1.02 [1-1.05],0.0955460370921088,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEMA3F,Semaphorin-3F,Inverse variance weighted,2,1.02 [1-1.05],0.0982399470813202,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LMNB2,Lamin-B2,Inverse variance weighted,2,1.05 [0.99-1.1],0.0987266933078966,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,2,1.02 [1-1.05],0.107539947654065,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,2,0.96 [0.91-1.01],0.108678052860831,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGAM,Integrin alpha-M,Inverse variance weighted,2,1.02 [0.99-1.05],0.109399701634278,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPL,N-acetylneuraminate lyase,Inverse variance weighted,2,1.04 [0.99-1.09],0.112038568564556,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,2,1.05 [0.99-1.12],0.112347653989668,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MVK,Mevalonate kinase,Inverse variance weighted,2,1.06 [0.99-1.14],0.112585432063125,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MMP7,Matrilysin,Inverse variance weighted,2,1.03 [0.99-1.07],0.113612444383153,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTN,Pleiotrophin,Inverse variance weighted,2,1.02 [0.99-1.05],0.119729488107471,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,2,1.03 [0.99-1.06],0.119834550546436,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,2,1.02 [0.99-1.05],0.122283292392143,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,2,1.02 [0.99-1.05],0.125087930001142,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,2,1.02 [0.99-1.05],0.125312005477808,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.05 [0.99-1.12],0.126056281244559,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPON1,Spondin-1,Inverse variance weighted,2,1.06 [0.98-1.15],0.129316653840002,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,2,1.02 [0.99-1.04],0.131178636330468,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ROBO2,Roundabout homolog 2,Inverse variance weighted,2,1.05 [0.99-1.11],0.132222085999784,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,2,1.03 [0.99-1.07],0.137252442877398,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,2,1.03 [0.99-1.08],0.140252975930488,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MATN2,Matrilin-2,Inverse variance weighted,2,1.02 [0.99-1.05],0.140739982488574,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,XCL1,Lymphotactin,Inverse variance weighted,2,1.02 [0.99-1.04],0.142957183211706,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF7,SLAM family member 7,Inverse variance weighted,2,1.02 [0.99-1.05],0.147680680004876,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AGRN,Agrin,Inverse variance weighted,2,1.02 [0.99-1.06],0.154148284574024,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,2,1.02 [0.99-1.05],0.156346094613543,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,2,1.01 [0.99-1.03],0.156773202874664,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,1.02 [0.99-1.05],0.157153181492301,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANPEP,Aminopeptidase N,Inverse variance weighted,2,1.04 [0.99-1.09],0.159889498148035,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GBP1,Guanylate-binding protein 1,Inverse variance weighted,2,1.06 [0.98-1.16],0.162453620902852,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGMN,Legumain,Inverse variance weighted,2,0.98 [0.95-1.01],0.162698849115814,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPQ,Carboxypeptidase Q,Inverse variance weighted,2,1.09 [0.97-1.23],0.163207673978096,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,2,1.02 [0.99-1.04],0.163846521390754,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,2,0.98 [0.95-1.01],0.163956231635058,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,2,1.03 [0.99-1.07],0.163982962252506,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,2,1.05 [0.98-1.12],0.167130525599336,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.05 [0.98-1.13],0.169929444339416,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RNASE6,Ribonuclease K6,Inverse variance weighted,2,1.02 [0.99-1.05],0.178396615894265,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,2,1.02 [0.99-1.05],0.184951996117345,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SORT1,Sortilin,Inverse variance weighted,2,0.98 [0.95-1.01],0.18629979682673,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH1,Cadherin-1,Inverse variance weighted,2,1.02 [0.99-1.05],0.188927657256586,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCP2,Non-specific lipid-transfer protein,Inverse variance weighted,2,1.02 [0.99-1.06],0.197398845701507,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSB,Cathepsin B,Inverse variance weighted,2,1.08 [0.96-1.21],0.197572372097667,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,2,1.07 [0.97-1.18],0.200818654271513,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL15,C-C motif chemokine 15,Inverse variance weighted,2,1.02 [0.99-1.04],0.205012910661749,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TCTN3,Tectonic-3,Inverse variance weighted,2,0.96 [0.91-1.02],0.217784635144302,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,2,1.02 [0.99-1.04],0.219555591952309,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,2,1.02 [0.99-1.05],0.219774982175732,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,2,1.02 [0.99-1.04],0.223376264486015,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,2,1.02 [0.99-1.04],0.225574362434168,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD59,CD59 glycoprotein,Inverse variance weighted,2,1.02 [0.99-1.04],0.227737063314221,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,Inverse variance weighted,2,1.02 [0.98-1.07],0.229198373027113,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,2,1.03 [0.98-1.08],0.230324335125725,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,2,1.02 [0.99-1.05],0.232765400806512,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSZ,Cathepsin Z,Inverse variance weighted,2,1.1 [0.94-1.27],0.234570636705339,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,2,1.04 [0.97-1.11],0.243844080066731,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,2,1.08 [0.95-1.23],0.245601308080061,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,2,1.03 [0.98-1.09],0.254221551555582,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.04 [0.97-1.13],0.258577162703104,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.02 [0.99-1.05],0.264869712760675,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VNN2,Vascular non-inflammatory molecule 2,Inverse variance weighted,2,1.01 [0.99-1.04],0.265289599435119,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,2,1.03 [0.98-1.07],0.27466103775748,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,2,1.02 [0.99-1.04],0.281525691660685,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HYAL1,Hyaluronidase-1,Inverse variance weighted,2,1.04 [0.97-1.12],0.28397105239708,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GRN,Progranulin,Inverse variance weighted,2,1.03 [0.97-1.09],0.28548436969035,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ASAH1,Acid ceramidase,Inverse variance weighted,2,1.03 [0.97-1.09],0.301961699713595,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,2,1.02 [0.98-1.07],0.311252467162479,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MUC13,Mucin-13,Inverse variance weighted,2,1.04 [0.97-1.11],0.312242714952535,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,2,1.01 [0.99-1.04],0.318321811216517,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,2,0.99 [0.96-1.01],0.322770026585115,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,Inverse variance weighted,2,1.02 [0.98-1.07],0.355250925495604,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.99 [0.95-1.02],0.363003602980915,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.01 [0.98-1.04],0.364707575746262,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,2,1.02 [0.98-1.07],0.375794484548746,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EDN1,Endothelin-1,Inverse variance weighted,2,1.01 [0.98-1.05],0.376815087546304,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEMA4C,Semaphorin-4C,Inverse variance weighted,2,0.99 [0.96-1.02],0.378905095380073,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PSAP,Prosaposin,Inverse variance weighted,2,1.02 [0.97-1.08],0.384451824317366,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGSF9,Protein turtle homolog A,Inverse variance weighted,2,1.02 [0.97-1.09],0.410379540182473,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Inverse variance weighted,2,0.99 [0.96-1.02],0.426181801129757,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHGA,Chromogranin-A,Inverse variance weighted,2,1.01 [0.98-1.04],0.428156569841385,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PON2,Serum paraoxonase/arylesterase 2,Inverse variance weighted,2,1.03 [0.96-1.11],0.436783319861351,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VTCN1,V-set domain-containing T-cell activation inhibitor 1,Inverse variance weighted,2,1.02 [0.96-1.09],0.444440698708872,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NME3,Nucleoside diphosphate kinase 3,Inverse variance weighted,2,1.02 [0.96-1.09],0.448226523707497,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,2,1.01 [0.98-1.04],0.449581322092816,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,2,1.01 [0.98-1.05],0.452174755431242,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.99 [0.95-1.02],0.455718038103649,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,2,1.02 [0.97-1.06],0.464814907386083,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,2,1.01 [0.98-1.04],0.467988529125149,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MME,Neprilysin,Inverse variance weighted,2,1.01 [0.98-1.04],0.478104029772043,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.99 [0.96-1.02],0.480785484293155,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,1.01 [0.98-1.04],0.516427447421486,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,2,0.99 [0.94-1.03],0.540485170835028,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF6,SLAM family member 6,Inverse variance weighted,2,1.01 [0.98-1.05],0.547587012814865,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BMP6,Bone morphogenetic protein 6,Inverse variance weighted,2,1.02 [0.96-1.08],0.564482483134743,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,2,0.98 [0.93-1.04],0.564496134390273,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,1.01 [0.98-1.03],0.573170928446843,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH17,Cadherin-17,Inverse variance weighted,2,1.01 [0.98-1.03],0.57408793720589,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.99 [0.95-1.03],0.574784224313912,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CFC1,Cryptic protein,Inverse variance weighted,2,1.01 [0.98-1.04],0.584661086238547,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",Inverse variance weighted,2,0.97 [0.87-1.08],0.585775872901182,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DIPK2B,Divergent protein kinase domain 2B,Inverse variance weighted,2,1.01 [0.97-1.05],0.590368603446724,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VAMP5,Vesicle-associated membrane protein 5,Inverse variance weighted,2,1.01 [0.98-1.04],0.598426374360474,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,2,0.99 [0.96-1.02],0.598591599355722,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,2,1.02 [0.95-1.09],0.602484102143442,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,2,1.01 [0.98-1.04],0.603544229200829,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,2,1.01 [0.96-1.07],0.611599405563477,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,2,1.01 [0.98-1.03],0.621003580858112,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,2,0.99 [0.95-1.03],0.626808848877913,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,2,0.99 [0.96-1.03],0.648667871704234,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,2,1.01 [0.98-1.03],0.658253224260377,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,Inverse variance weighted,2,1.01 [0.98-1.04],0.672341805178558,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NECTIN2,Nectin-2,Inverse variance weighted,2,0.99 [0.96-1.03],0.674072711086565,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD27,CD27 antigen,Inverse variance weighted,2,1.01 [0.98-1.03],0.683900639878024,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGALS4,Galectin-4,Inverse variance weighted,2,1.01 [0.98-1.03],0.68525508046434,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,2,0.99 [0.97-1.02],0.689682223765126,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,2,1.02 [0.92-1.14],0.706866163243525,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KITLG,Kit ligand,Inverse variance weighted,2,0.97 [0.85-1.12],0.718664303886128,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,APOA2,Apolipoprotein A-II,Inverse variance weighted,2,1.02 [0.91-1.14],0.726824805730219,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,2,1 [0.97-1.02],0.730302728489015,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOMO1,Nodal modulator 1,Inverse variance weighted,2,1 [0.98-1.03],0.73151245601152,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,2,1 [0.98-1.03],0.741763323719613,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NT5E,5'-nucleotidase,Inverse variance weighted,2,1 [0.97-1.02],0.752552690840421,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,2,1.01 [0.96-1.06],0.769076623460761,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PODXL,Podocalyxin,Inverse variance weighted,2,1 [0.98-1.03],0.781762468718543,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL21,C-C motif chemokine 21,Inverse variance weighted,2,1 [0.97-1.02],0.79345807714703,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,2,1 [0.98-1.03],0.80328143489319,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD302,CD302 antigen,Inverse variance weighted,2,1 [0.97-1.04],0.803330287867458,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,2,1 [0.98-1.03],0.817346411194574,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,2,0.99 [0.9-1.09],0.817949471779183,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPM,Carboxypeptidase M,Inverse variance weighted,2,1 [0.96-1.05],0.818704453880702,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MMP10,Stromelysin-2,Inverse variance weighted,2,1 [0.97-1.02],0.841089340634207,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFNGR2,Interferon gamma receptor 2,Inverse variance weighted,2,0.99 [0.92-1.07],0.855676052048851,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LEPR,Leptin receptor,Inverse variance weighted,2,1 [0.97-1.03],0.858215588893495,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,2,1 [0.98-1.03],0.85951232442008,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAMP2,Lysosome-associated membrane glycoprotein 2,Inverse variance weighted,2,1 [0.97-1.03],0.865641461358034,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1 [0.96-1.03],0.875506445197286,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,Inverse variance weighted,2,0.99 [0.92-1.08],0.887069975848142,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADA,Adenosine deaminase,Inverse variance weighted,2,1 [0.96-1.05],0.897662312730374,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,2,1 [0.97-1.03],0.899873636272874,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,2,1 [0.97-1.03],0.902487322356204,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SHISA5,Protein shisa-5,Inverse variance weighted,2,1 [0.97-1.03],0.90970268658738,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDHB,Succinate dehydrogenase,Inverse variance weighted,2,1 [0.94-1.08],0.912966774347753,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TFF2,Trefoil factor 2,Inverse variance weighted,2,1 [0.97-1.03],0.927579589458633,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,1 [0.97-1.04],0.931688899242485,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,2,1 [0.97-1.03],0.941286129266384,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,2,1 [0.97-1.03],0.952688937675607,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,2,1 [0.97-1.03],0.959777285378181,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,2,1 [0.97-1.03],0.96874820934367,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,2,1 [0.97-1.03],0.971814260823412,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CES1,Liver carboxylesterase 1,Inverse variance weighted,2,1 [0.87-1.15],0.977501347085008,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RNASET2,Ribonuclease T2,Inverse variance weighted,2,1 [0.95-1.05],0.983207454887664,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HMOX2,Heme oxygenase 2,Inverse variance weighted,2,1 [0.95-1.05],0.988501571173373,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,2,1 [0.94-1.06],0.993456352153059,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,2,1 [0.94-1.07],0.996779072648117,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DLL1,Delta-like protein 1,Inverse variance weighted,2,1 [0.97-1.04],0.996881766462285,trans
